Lipodystrophia with protease inhibitors in HIV patients

Therapie

Volumn 52, Issue 6, 1997, Pages 615-

  Massip, P ^a   Marchou, B ^a   Bonnet, E ^a   Cuzin, L ^a   Montastruc, J L ^b  

^a CHU PURPAN   (France)

^b Service de Pharmacologie Clinique   (France)

Author keywords

HIV protease inhibitor; Lipodystrophia

Indexed keywords

DIDANOSINE; INDINAVIR; LAMIVUDINE; PROTEINASE; PROTEINASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; MALE; PRIORITY JOURNAL;

HIV INFECTIONS; HUMANS; LIPODYSTROPHY; PROTEASE INHIBITORS;

EID: 6844265598     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Anonymous. Diabetes score for protease inhibitors. Scrip 1997; 2242: 21.
2. Anonymous. Hemolytic anaemia warnings with indinavir. Scrip 1997; 2235: 20.
3. Begaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisée en France. Therapie 1985; 40: 111-118.